![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Pk Chemicals A/s Koge Dk, based in Denmark, is a pharmaceutical company.
One of their significant offerings is Malathion, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2017-213 - Rev 00
This Chemical Type CEP, issued on June 19, 2019, remains in force until February 13, 2023, ensuring its reliability within the pharmaceutical industry.
Substance Number 1343 associated with this CEP further emphasizes